Y. Kanda-Kimura

Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.

T. Mune, K. Kaku, M. Shimoda, 2013, Diabetes research and clinical practice.

Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytes.

M. Matsuda, H. Kaneto, T. Mune, 2015, Endocrine journal.

Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.

H. Kaneto, T. Mune, K. Kaku, 2018, Diabetes & metabolism.

Low bilirubin levels are an independent risk factor for diabetic retinopathy and nephropathy in Japanese patients with type 2 diabetes.

H. Kaneto, T. Mune, K. Kaku, 2015, Diabetes & metabolism.

Influence of atherosclerosis‐related risk factors on serum high‐sensitivity C‐reactive protein levels in patients with type 2 diabetes: Comparison of their influence in obese and non‐obese patients

H. Kaneto, T. Mune, K. Kaku, 2015, Journal of diabetes investigation.

Seven-year Observational Study on the Association between Glycemic Control and the New Onset of Macroangiopathy in Japanese Subjects with Type 2 Diabetes.

H. Kaneto, T. Mune, K. Kaku, 2016, Internal medicine.

Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β‐cells in db/db mice: The earlier and longer, the better

H. Kaneto, T. Mune, K. Kaku, 2018, Diabetes, obesity & metabolism.